BNP Paribas Financial Markets
TYRA icon

BNP Paribas Financial Markets’s Tyra Biosciences TYRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.67M Buy
240,227
+50,188
+26% +$1.66M ﹤0.01% 1798
2026
Q1 		$7.28M Buy
190,039
+69,761
+58% +$2.26M ﹤0.01% 1760
2025
Q4 		$3.16M Sell
120,278
-8,603
-7% -$158K ﹤0.01% 2329
2025
Q3 		$1.8M Buy
128,881
+31,145
+32% +$355K ﹤0.01% 2681
2025
Q2 		$935K Buy
97,736
+28,786
+42% +$274K ﹤0.01% 2949
2025
Q1 		$641K Buy
68,950
+64,632
+1,497% +$836K ﹤0.01% 3036
2024
Q4 		$60K Buy
+4,318
New +$78.4K ﹤0.01% 4351

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BNP Paribas Financial Markets's TYRA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Tyra Biosciences (TYRA) stake by 26% in Q2 2026, buying an estimated $1.66M and bringing the position to 240,227 shares worth $7.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

BNP Paribas Financial Markets first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • BNP Paribas Financial Markets held 240,227 shares of Tyra Biosciences worth $7.67M as of Q2 2026.
  • BNP Paribas Financial Markets bought 50,188 Tyra Biosciences shares in Q2 2026, an estimated $1.66M.
  • Tyra Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1798 holding.
  • BNP Paribas Financial Markets first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.